The Global Burden of Neurovascular Interventions: Epidemiology and Statistics
I. Introduction
Neurological disorders represent a significant and growing global health challenge, impacting millions worldwide and imposing substantial burdens on healthcare systems and economies. Among these, neurovascular diseases, encompassing conditions such as stroke, cerebral aneurysms, and arteriovenous malformations (AVMs), are particularly devastating, often leading to severe disability or death. Understanding the global epidemiology and statistics surrounding these conditions, as well as the interventions developed to address them, is crucial for effective public health strategies, resource allocation, and the advancement of medical science. This article delves into the global burden of neurovascular interventions, exploring the prevalence, incidence, and impact of these diseases. It also examines the evolving landscape of neurovascular interventions and the challenges associated with access to care. This article is intended for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment.
II. Epidemiology of Neurovascular Diseases
A. Global Prevalence and Incidence
Neurological conditions collectively represent the leading cause of illness and disability globally. A landmark study published in The Lancet Neurology revealed that in 2021, over 3.4 billion individuals, representing 43.1% of the global population, were affected by a neurological condition [2] [3] [5]. These conditions were responsible for 11.1 million deaths in the same year [5].
Stroke, a critical component of neurovascular disease, remains a leading cause of death and long-term disability worldwide. Globally, one in four adults over the age of 25 will experience a stroke in their lifetime [11]. The incidence and prevalence of stroke continue to rise, particularly in low- and middle-income countries (LMICs), where the majority of the burden (78.5% of deaths and 77.3% of disability-adjusted life years - DALYs) is concentrated [6]. For instance, nearly 7.9 million people are currently living with the aftermath of a subarachnoid hemorrhage (SAH) globally [7]. The overall burden of neurological disorders, including neurovascular diseases, accounted for 276 million DALYs in 2016, making them the leading cause of DALYs and the second leading cause of deaths globally [1] [6].
B. Risk Factors
The development and progression of neurovascular diseases are influenced by a complex interplay of various risk factors. Hypertension, diabetes mellitus, dyslipidemia, smoking, obesity, and physical inactivity are well-established modifiable risk factors that significantly increase the likelihood of stroke and other neurovascular events. Non-modifiable risk factors include age, genetics, and ethnicity. The global aging population is a significant demographic trend contributing to the increasing burden of neurovascular diseases, as the risk of these conditions rises substantially with age. Addressing these risk factors through public health initiatives and individual lifestyle modifications is paramount in mitigating the global burden.
III. The Burden of Neurovascular Interventions
A. Types of Neurovascular Interventions
Neurovascular interventions encompass a range of medical procedures designed to treat conditions affecting the blood vessels of the brain and spinal cord. These interventions can be broadly categorized into endovascular and surgical approaches. Endovascular techniques, which are minimally invasive, include procedures such as mechanical thrombectomy for acute ischemic stroke, coiling or flow diversion for cerebral aneurysms, and embolization for AVMs. Surgical interventions, such as aneurysm clipping or AVM resection, are also critical in managing complex neurovascular pathologies. Advances in imaging technologies, catheter design, and device development have revolutionized the field, making these interventions safer and more effective.
B. Trends in Interventions
The neurovascular intervention market is experiencing robust growth, driven by an expanding treatable patient population, increased awareness, and continuous innovation in medical devices and techniques [12]. Key trends observed in 2024 and beyond include the widespread adoption of minimally invasive techniques, which offer reduced recovery times and improved patient outcomes. Advanced imaging modalities, such as high-resolution MRI and CT angiography, play a crucial role in precise diagnosis and treatment planning. The integration of robotics in neurovascular surgery is also emerging, promising enhanced precision and control during complex procedures. Furthermore, personalized medicine approaches, tailored to individual patient characteristics and disease profiles, are gaining traction, aiming to optimize treatment efficacy and minimize adverse events [14].
C. Challenges and Disparities in Access
Despite significant advancements, substantial challenges and disparities persist in the global landscape of neurovascular interventions. Access to specialized neurovascular care, including diagnostic facilities and interventional expertise, remains highly uneven across different regions. LMICs, in particular, face significant hurdles due to limited infrastructure, a shortage of trained personnel, and economic constraints [6]. This disparity contributes to higher rates of disability and mortality from neurovascular diseases in these regions. The economic burden of neurovascular interventions, including the cost of devices, procedures, and long-term rehabilitation, also poses a significant challenge for healthcare systems worldwide, necessitating innovative solutions for cost-effective care delivery.
IV. Key Statistics and Data
| Statistic Category | Data Point | Source | Year | Additional Information | | :----------------- | :--------- | :----- | :--- | :--------------------- | | Global Neurological Conditions | 3.4 billion affected | The Lancet Neurology [2] [3] [5] | 2021 | 43.1% of global population | | Deaths from Neurological Conditions | 11.1 million | The Lancet Neurology [5] | 2021 | | | DALYs from Neurological Disorders | 276 million | GBD Study [1] [6] | 2016 | Leading cause of DALYs | | Stroke Lifetime Risk | 1 in 4 adults over 25 | World Stroke Organization [11] | Ongoing | | | SAH Prevalence | 7.9 million living with SAH | World Stroke Organization [7] | Ongoing | | | Neurovascular Intervention Market CAGR | 8.33% | DelveInsight [13] | 2025-2032 | Forecasted growth |
V. Future Outlook and Conclusion
The global burden of neurovascular diseases and the demand for effective interventions are projected to continue rising, driven by demographic shifts and the increasing prevalence of risk factors. Continued investment in research and development is essential to foster innovative diagnostic tools, therapeutic strategies, and interventional devices. Emphasis on early diagnosis, rapid intervention, and comprehensive post-procedural care is crucial for improving patient outcomes and reducing the long-term societal impact of these conditions. INVAMED is committed to addressing this global health challenge by developing cutting-edge neurovascular technologies and supporting initiatives that enhance access to life-saving interventions worldwide.
VI. Disclaimer
This article is for informational purposes only and does not constitute medical advice. The content provided herein is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.
VII. References
[1] a systematic analysis for the Global Burden of Disease Study 2016. (2025, March 11). *PMC*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC6459001/](https://pmc.ncbi.nlm.nih.gov/articles/PMC6459001/) [2] a systematic analysis for the Global Burden of Disease Study 2021. (n.d.). *The Lancet*. [https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00038-3/fulltext](https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00038-3/fulltext) [3] Over 1 in 3 people affected by neurological conditions, the leading ... (2024, March 14). *WHO*. [https://www.who.int/news/item/14-03-2024-over-1-in-3-people-affected-by-neurological-conditions--the-leading-cause-of-illness-and-disability-worldwide](https://www.who.int/news/item/14-03-2024-over-1-in-3-people-affected-by-neurological-conditions--the-leading-cause-of-illness-and-disability-worldwide) [4] US Burden of Disorders Affecting the Nervous System - JAMA Network. (2025, November 24). *JAMA Network*. [https://jamanetwork.com/journals/jamaneurology/fullarticle/2841765](https://jamanetwork.com/journals/jamaneurology/fullarticle/2841765) [5] The Global Prevalence of Brain Disease - American Brain Foundation. (2024, July 2). *American Brain Foundation*. [https://www.americanbrainfoundation.org/the-global-prevalence-of-brain-disease/](https://www.americanbrainfoundation.org/the-global-prevalence-of-brain-disease/) [6] The global burden of neurological disorders - PMC - NIH. (n.d.). *PMC*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC9945815/](https://pmc.ncbi.nlm.nih.gov/articles/PMC9945815/) [7] World Stroke Organization: Global Stroke Fact Sheet 2025 - PMC. (n.d.). *PMC*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC11786524/](https://pmc.ncbi.nlm.nih.gov/articles/PMC11786524/) [8] Abstract 169: Neurovascular Disease is the Second Leading Cause ... (2018, January 22). *AHA Journals*. [https://www.ahajournals.org/doi/10.1161/str.49.suppl_1.169](https://www.ahajournals.org/doi/10.1161/str.49.suppl_1.169) [9] WHO Report Finds Neurological Conditions Now Affect Over One ... (2025, October 17). *WF Neurology*. [https://wfneurology.org/activities/news-events/archived-news/2025-10-17-wcn2025-who-report-1-in-3-neurological-conditions](https://wfneurology.org/activities/news-events/archived-news/2025-10-17-wcn2025-who-report-1-in-3-neurological-conditions) [10] An Overview of Neurovascular Disease Management - PMC. (n.d.). *PMC*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC4300058/](https://pmc.ncbi.nlm.nih.gov/articles/PMC4300058/) [11] Impact of Stroke - World Stroke Organization. (n.d.). *World Stroke Organization*. [https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke](https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke) [12] Key Trends in Neurovascular Intervention for 2024. (2024, May 21). *Smarttrak*. [https://blog.smarttrak.com/key-trends-in-neurovascular-intervention-for-2024](https://blog.smarttrak.com/key-trends-in-neurovascular-intervention-for-2024) [13] Neurovascular Devices Market Size, Forecast, Outlook. (n.d.). *DelveInsight*. [https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market](https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market) [14] Exploring Future Trends in Neurovascular Surgery. (2024, November 20). *Igea Neuro*. [https://www.igeaneuro.com/blogs/future-trends-in-neurovascular-surgery.php](https://www.igeaneuro.com/blogs/future-trends-in-neurovascular-surgery.php) [15] Neurovascular surgery: a review of the way forward from the American perspective. (2024). *AME Surgical Journal*. [https://journals.lww.com/asj/fulltext/2024/12000/neurovascular_surgery__a_review_of_the_way_forward.5.aspx](https://journals.lww.com/asj/fulltext/2024/12000/neurovascular_surgery__a_review_of_the_way_forward.5.aspx) [16] Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission. (n.d.). *The Lancet*. [https://www.thelancet.com/article/S1474-4422(23)00277-6/abstract](https://www.thelancet.com/article/S1474-4422(23)00277-6/abstract) [17] Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. (n.d.). *PMC*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC10685084/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10685084/) [18] Cerebral vascular disease and neurovascular injury in ischemic stroke. (n.d.). *AHA Journals*. [https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.116.308427](https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.116.308427) [19] Neurovascular disease, diagnosis, and therapy: Brain aneurysms. (n.d.). *ScienceDirect*. [https://www.sciencedirect.com/science/article/pii/B9780444640345000018](https://www.sciencedirect.com/science/article/pii/B9780444640345000018) [20] The global burden of neurological disorders: translating evidence into policy. (n.d.). *The Lancet*. [https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30411-9/abstract](https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30411-9/abstract) [21] Trends in Neurointervention. (2014). *Springer*. [https://link.springer.com/content/pdf/10.1007/978-3-319-02411-0.pdf](https://link.springer.com/content/pdf/10.1007/978-3-319-02411-0.pdf)